Abstract
Relevance: Renal cell carcinoma (RCC), the most common type of kidney cancer, poses a significant health burden worldwide. Despite advancements in diagnostic techniques and treatment modalities, RCC remains a formidable challenge due to its heterogeneous nature, varied clinical presentations, and complex molecular landscape. Understanding the intricacies of RCC is crucial for improving patient outcomes, optimizing therapeutic strategies, and advancing personalized medicine approaches. The study aimed to investigate the feasibility and outcomes of simultaneous surgeries in patients with kidney cancers and heart diseases, aiming to address the current centralization of specialized care. Methods: The authors evaluated and analyzed five cases of simultaneous surgeries performed at the National Scientific Medical Center (Astana, Kazakhstan) from January 2012 to December 2023. Each case provides unique insights into the diagnostic challenges, treatment dilemmas, and long-term outcomes associated with RCC. Results: From January 2012 to December 2023, we evaluated and analyzed 5 cases of simultaneous surgeries at the National Scientific Medical Center, Astana. Each case offers unique insights into the diagnostic challenges, treatment dilemmas, and long-term outcomes associated with RCC. Conclusion: Simultaneous surgeries for RCC and concomitant diseases represent a viable approach to optimize patient care and streamline treatment. These cases demonstrate the successful management of RCC alongside various comorbidities, highlighting the importance of multidisciplinary collaboration and careful surgical planning. By addressing multiple conditions in a single procedure, simultaneous surgeries offer a promising strategy to improve outcomes and enhance patient satisfaction in managing RCC.